Distributed Manufacturing in MedicineNick Lambert | CEO, Dock LabsJim Nasr | CEO, Acoer ModeratorThe conversation pivots around what is actually working now in the blockchain in healthcare field including:
- Current trends in DIDs…what’s working, what’s not
- Usability and wallets
- Blockchain for medicine – is it helping decrease counterfeit medicine production?
- Decentralization, collaboration, and efficiency
- Advantages & disadvantages on decentralizing Pharma manufacturing
- Implications of collaborations, cross-border transactions for blockchain-enabled transactions and impact of immutability
- Interoperability, scalability, and economic viability for life sciences
- Regulation and the implications in life sciences
- Tokenization & Web 3 trends
- How to increase adoption and what the incentives are for Pharma
- Prediction(s)
